Novel detox gel depot sequesters β-amyloid peptides in a mouse model of Alzheimer's disease

International Journal of Peptide Research and Therapeutics

Volumn 18, Issue 2, 2012, Pages 99-106

  Sundaram, Ranjini K ^a   Kasinathan, Chinnaswamy ^b   Stein, Stanley ^c   Sundaram, Pazhani ^a  

^a Recombinant Technologies LLC   (United States)

^b RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Beta amyloid; Detox gel; Peripheral sink; Retro inverse peptide

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; PEPTIDE; PHENYLALANYLPHENYLALANYLVALINYLLYSINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYLOID BETA PROTEIN BRAIN LEVEL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BRAIN LEVEL; COGNITION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; GEL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAZE TEST; MOUSE; NONHUMAN; TREATMENT RESPONSE;

MUS;

EID: 84860841576     PISSN: 15733149     EISSN: 15733904     Source Type: Journal    
DOI: 10.1007/s10989-011-9283-7     Document Type: Article

References (23)

1. Bayer AJ, Bullock R, Jones RW, Wilkinson D, Paterson KR, Jenkins L, Millais SB, Donoghue S (2005) Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD. Neurology 64:94-101 (Pubitemid 40082943)
2. Chorev M, Goodman M (1995) Recent developments in retro peptides and proteins - an ongoing topochemical exploration. Trends Biotechnol 13:438-445
3. Demattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM (2002) Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 295:2264-2267 (Pubitemid 34258840)
4. Dintzis HM, Symer DE, Dintzis RZ, Zawadzke LE, Berg JM (1993) A comparison of the immunogenicity of a pair of enantiomeric proteins. Proteins 16:306-308 (Pubitemid 23183306)
5. Herve M, Maillere B, Mourier G, Texier C, Leroy S, Menez A (1997) On the immunogenic properties of retro-inverso peptides. Total retro-inversion of T-cell epitopes causes a loss of binding to MHC II molecules. Mol Immunol 34:157-163 (Pubitemid 27242697)
6. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4:97-100 (Pubitemid 28133087)
7. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274: 99-102 (Pubitemid 26332733)
8. Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG (2001) Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 21:372-381 (Pubitemid 32107428)
9. King DL, Arendash GW (2002) Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. Physiol Behav 75:627-642 (Pubitemid 34521825)
10. Kokkoni N, Stott K, Amijee H, Mason JM, Doig AJ (2006) N-methylated peptide inhibitors of beta-amyloid aggregation and toxicity. Optimization of the inhibitor structure. Biochemistry 45:9906-9918 (Pubitemid 44257436)
11. Matsuoka Y, Saito M, Lafrancois J, Gaynor K, Olm V, Wang L, Casey E, Lu Y, Shiratori C, Lemere C, Duff K (2003) Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to betaamyloid. J Neurosci 23:29-33 (Pubitemid 36050401)
12. Morgan D, Gordon MN (2008) Amyloid, hyperactivity, metabolism: theoretical comment on Vloeberghs et al. (2008). Behav Neurosci 122:730-732 (Pubitemid 351787852)
13. Orgogozo JM, Gilman S, Dartigues JF, Laurent B, Puel M, Kirby LC, Jouanny P, Dubois B, Eisner L, Flitman S, Michel BF, Boada M, Frank A, Hock C (2003) Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 61:46-54 (Pubitemid 36818745)
14. Sagare A, Deane R, Bell RD, Johnson B, Hamm K, Pendu R, Marky A, Lenting PJ, Wu Z, Zarcone T, Goate A, Mayo K, Perlmutter D, Coma M, Zhong Z, Zlokovic BV (2007) Clearance of amyloid-beta by circulating lipoprotein receptors. Nat Med 13:1029-1031 (Pubitemid 47517512)
15. Selkoe DJ (1996) Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem 271:18295-18298 (Pubitemid 26322675)
16. Sigurdsson EM, Scholtzova H, Mehta PD, Frangione B, Wisniewski T (2001) Immunization with a nontoxic/nonfibrillar amyloidbeta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice. Am J Pathol 159:439-447 (Pubitemid 32751074)
17. Small DH, Mok SS, Bornstein JC (2001) Alzheimer's disease and Abeta toxicity: from top to bottom. Nat Rev Neurosci 2:595-598 (Pubitemid 33679833)
18. Soto C, Sigurdsson EM, Morelli L, Kumar RA, Castano EM, Frangione B (1998) Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med 4:822-826 (Pubitemid 28331024)
19. Strazielle N, Ghersi-Egea JF, Ghiso J, Dehouck MP, Frangione B, Patlak C, Fenstermacher J, Gorevic P (2000) In vitro evidence that beta-amyloid peptide 1-40 diffuses across the blood-brain barrier and affects its permeability. J Neuropathol Exp Neurol 59:29-38 (Pubitemid 30069223)
20. Sundaram RK, Kasinathan C, Stein S, Sundaram P (2008) Detoxification depot for beta-amyloid peptides. Curr Alzheimer Res 5:26-32
21. Tjernberg LO, Lilliehook C, Callaway DJ, Naslund J, Hahne S, Thyberg J, Terenius L, Nordstedt C (1997) Controlling amyloid beta-peptide fibril formation with protease-stable ligands. J Biol Chem 272:12601-12605 (Pubitemid 27203354)
22. Tjernberg LO, Näslund J, Lindqvist F, Johansson J, Karlström AR, Thyberg J, Terenius L, Nordstedt C (1996) Arrest of betaamyloid fibril formation by a pentapeptide ligand. J Biol Chem 271(15):8545-8548 (Pubitemid 26123269)
23. Zhang G, Leibowitz MJ, Sinko PJ, Stein S (2003) Multiple-peptide conjugates for binding beta-amyloid plaques of Alzheimer's disease. Bioconjugate Chem 14:86-92 (Pubitemid 36169021)